TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03219164

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“Study was terminated early by sponsor due to the challenges and risks introduced by Coronavirus disease 2019 (COVID-19) pandemic.”

The sponsor’s own words in the registry.

Life of this trial

2017201820192020202120222023Registered2017-07-13Started2017-11-28Primary completion2020-05-27Stopped2021-09-23Results posted2022-05-16

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
Gilead Sciences
Sponsor type
Industry
Conditions
Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization; Cystic Fibrosis
Interventions
AZLI; Placebo
Participants
149
Sites
53
Countries
Austria, Belgium, Denmark, France, Germany, Greece, Israel, Italy, Netherlands, Spain, United Kingdom, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.